Thomas J. Schaefer

Thomas J. Schaefer is recorded as Chief Accounting Officer at Arcadia Biosciences, Inc. (RKDA) since September 12, 2025, Board Member at Arcadia Biosciences, Inc. (RKDA) since August 1, 2024, CEO at Arcadia Biosciences, Inc. (RKDA) since July 5, 2024 and CFO at Arcadia Biosciences, Inc. (RKDA). The newest filing on record that lists Thomas J. Schaefer as CEO at Arcadia Biosciences, Inc. (RKDA) is dated August 10, 2026. The newest filing on record that lists Thomas J. Schaefer as CFO at Arcadia Biosciences, Inc. (RKDA) is dated May 16, 2024. Arcadia Biosciences, Inc. reported in an 8-K filed August 29, 2025 that Thomas J. Schaefer was appointed principal accounting officer, effective September 12, 2025. Arcadia Biosciences, Inc. reported in an 8-K filed August 29, 2025 that Thomas J. Schaefer was appointed Interim Chief Financial Officer, effective September 12, 2025. Arcadia Biosciences, Inc. reported in an 8-K filed August 7, 2024 that Thomas J. Schaefer was appointed Class I director, effective August 1, 2024. Equibles holds 5 filed executive changes naming Thomas J. Schaefer; each is listed under recent activity with its source filing. The proxy statement of Arcadia Biosciences, Inc. reports total compensation of $469,001 for Thomas J. Schaefer in fiscal 2025, including a base salary of $260,000. Disclosed compensation is on record for 4 fiscal years. Arcadia Biosciences, Inc. is classified in the Packaged Foods industry within the Consumer Defensive sector. Other leadership on record at Arcadia Biosciences, Inc. includes Kevin Comcowich (CEO), Rajendra Ketkar (CEO), Stan Jacot (CEO) and 7 others.